Once known mainly for their role in weight management, GLP-1 receptor agonists, like semaglutide and tirzepatide, are now ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

The GLP-1 medication program by MedVi is now available nationwide starting at $179. NEWARK, DE - MedVi Wellness, a leading tele ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Another study linked GLP-1 receptor agonist use with higher odds of developing nonarteritic anterior ischemic optic ...

GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema.